JP2006505280A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006505280A5 JP2006505280A5 JP2004551842A JP2004551842A JP2006505280A5 JP 2006505280 A5 JP2006505280 A5 JP 2006505280A5 JP 2004551842 A JP2004551842 A JP 2004551842A JP 2004551842 A JP2004551842 A JP 2004551842A JP 2006505280 A5 JP2006505280 A5 JP 2006505280A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- cells
- dendritic cell
- nucleic acid
- activate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004443 dendritic cell Anatomy 0.000 claims 17
- 239000002773 nucleotide Substances 0.000 claims 13
- 125000003729 nucleotide group Chemical group 0.000 claims 13
- 108020004707 nucleic acids Proteins 0.000 claims 9
- 150000007523 nucleic acids Chemical class 0.000 claims 9
- 102000039446 nucleic acids Human genes 0.000 claims 9
- 210000001744 T-lymphocyte Anatomy 0.000 claims 8
- 241000713666 Lentivirus Species 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 108020004459 Small interfering RNA Proteins 0.000 claims 5
- 102000004127 Cytokines Human genes 0.000 claims 4
- 108090000695 Cytokines Proteins 0.000 claims 4
- 108010002586 Interleukin-7 Proteins 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 3
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 230000001771 impaired effect Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42460202P | 2002-11-07 | 2002-11-07 | |
| PCT/US2003/035482 WO2004044147A2 (en) | 2002-11-07 | 2003-11-07 | Modified dendritic cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006505280A JP2006505280A (ja) | 2006-02-16 |
| JP2006505280A5 true JP2006505280A5 (https=) | 2006-12-14 |
Family
ID=32312839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004551842A Pending JP2006505280A (ja) | 2002-11-07 | 2003-11-07 | 改変樹状細胞 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060013803A1 (https=) |
| EP (1) | EP1562635A4 (https=) |
| JP (1) | JP2006505280A (https=) |
| CN (1) | CN1708320A (https=) |
| AU (1) | AU2003287557A1 (https=) |
| CA (1) | CA2505403A1 (https=) |
| WO (1) | WO2004044147A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090010948A1 (en) * | 2006-12-15 | 2009-01-08 | The University Of Hong Kong | Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10 |
| HUE035406T2 (en) * | 2007-10-08 | 2018-05-02 | Intrexon Corp | Engineered dendritic cells and uses for the treatment of cancer |
| WO2014145631A1 (en) * | 2013-03-15 | 2014-09-18 | The Broad Institute, Inc. | Dendritic cell response gene expression, compositions of matters and methods of use thereof |
| CN103834691B (zh) * | 2014-01-21 | 2016-06-29 | 宁波大学 | 靶向il-33基因rna干扰重组慢病毒载体的构建方法 |
| CN108350037A (zh) | 2015-11-09 | 2018-07-31 | 免疫设计股份有限公司 | 包含表达il-12的慢病毒载体的组合物及其使用方法 |
| CN108676815A (zh) * | 2018-05-31 | 2018-10-19 | 深圳市免疫基因治疗研究院 | 一种b型血友病慢病毒载体、慢病毒及其制备方法和应用 |
| CN111647563A (zh) * | 2020-08-06 | 2020-09-11 | 北京翊博普惠生物科技发展有限公司 | 靶向Survivin全抗原的DC细胞、CTL细胞及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965535A (en) * | 1997-09-12 | 1999-10-12 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
| JP2000004883A (ja) * | 1998-06-24 | 2000-01-11 | Hisamitsu Pharmaceut Co Inc | Ｉｌ−１０蛋白の発現を阻害するアンチセンスオリゴヌクレオチド |
| DE19956568A1 (de) * | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| DK1175497T3 (da) * | 1999-04-14 | 2010-05-31 | Novartis Vaccines & Diagnostic | Præparater og fremgangsmåder til generering af et immunrespons ved udnyttelse af alfavirusbaserede vektorsystemer |
| CA2392010A1 (en) * | 1999-08-27 | 2001-03-08 | Regents Of The University Of California | Use of lentiviral vectors for antigen presentation in dendritic cells |
| US6627442B1 (en) * | 2000-08-31 | 2003-09-30 | Virxsys Corporation | Methods for stable transduction of cells with hiv-derived viral vectors |
| GB0130955D0 (en) * | 2001-12-24 | 2002-02-13 | Cancer Res Ventures | Expression system |
-
2003
- 2003-11-07 JP JP2004551842A patent/JP2006505280A/ja active Pending
- 2003-11-07 CA CA002505403A patent/CA2505403A1/en not_active Abandoned
- 2003-11-07 WO PCT/US2003/035482 patent/WO2004044147A2/en not_active Ceased
- 2003-11-07 CN CN200380102586.2A patent/CN1708320A/zh active Pending
- 2003-11-07 EP EP03781799A patent/EP1562635A4/en not_active Withdrawn
- 2003-11-07 AU AU2003287557A patent/AU2003287557A1/en not_active Abandoned
-
2005
- 2005-05-05 US US11/122,456 patent/US20060013803A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boucher et al. | Local mobile gene pools rapidly cross species boundaries to create endemicity within global Vibrio cholerae populations | |
| WO2001092572A1 (en) | Kit and method for determining hla type | |
| AU2003297244A1 (en) | Methods and compositions for purification of nucleic acid from a host cell | |
| AU2002348563A1 (en) | Nucleic acid enrichment | |
| EP2722387A3 (en) | Definitive endoderm | |
| WO2003068926A3 (en) | Over-expression of extremozyme genes in pseudomonads and closely related bacteria | |
| WO2003018751A3 (en) | Apparatus and method for electroporation of biological samples | |
| EP2628799A3 (en) | RNAi modulation of RSV and therapeutic uses thereof | |
| AU2003234196A1 (en) | Functionalized nanoparticles and methods of use | |
| EP1572943A4 (en) | CIRCULAR NUCLEIC ACID VECTORS AND PROCESS FOR THE PRODUCTION AND USE THEREOF | |
| Burow et al. | Identification of d esulfobacterales as primary hydrogenotrophs in a complex microbial mat community | |
| DK1407022T3 (da) | Fremgangsmåder til at fremstille L-amonosyrer ved at anvende stammer af Enterobacteriaceae familien som indeholder et forstærket rseA-gen | |
| EP2287178A3 (en) | Bacillus licheniformis YvmC inactivation | |
| PE20060952A1 (es) | Microorganismos productores de acido l-glutamico y metodo para la produccion de acido l-glutamico | |
| UA42675C2 (uk) | Спосіб активації гена, що в нормі транскрипційно мовчить, з геному еукаріотичної клітинної лінії, спосіб модифікації характеристик експресії гена з геному еукаріотичної клітинної лінії, диференційована еукаріотична клітинна лінія (варіанти), днк-конструкт | |
| NO922381L (no) | Stabil integrering av dna i bakteriegenomer | |
| JP2006526394A5 (https=) | ||
| JP2006505280A5 (https=) | ||
| DE60043779D1 (de) | Genetisch veränderte dendritische zellen, die mit adeno-assoziiertem virus transduziert wurden, verfahren zur herstellung dieser zellen und ihre verwendungen | |
| WO2004013333A3 (de) | Revertierung der negativ-selektiven wirkung von negativen markerproteinen als selektionsverfahren | |
| WO2004052527A8 (de) | Verfahren und reaktor zur amplifikation von dna | |
| WO2003089617A3 (en) | Methods for increasing homologous recombination of a nucleic acid sequence | |
| AU2003234932A1 (en) | Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers | |
| WO2004044147A3 (en) | Modified dendritic cells | |
| DE60130465D1 (de) | Mutierte muskelspezifische enhancer |